This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Register to attend this important, free webinar on NASH
Get ready to hear an engaging, important discussion about the quest for the first drugs to treat nonalcoholic steatohepatitis (NASH) and the competitive environment that is sure to follow. Listen to our experts discuss:
New and repurposed drugs in development, including Intercept’s which may be the first to market
Various licensing, partnership and M&A deals
The challenges to develop treatment for a disease with numerous targets and pathways